JonathanRaymondFrommMD

PubMed

• CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell m...
  Wang, H., Koob, T., Carter, D., Lieber, A., Fromm, J., Gopal, A.> ;Cancer Biology & Therapy. 2024 Dec 31
• Use of CD32, CD44 and CD71 to differentiate follicular lymphoma and diffuse large B-cell lymphoma subtypes by flow cytometry.
  Schwarz, L., Love, J., Shameli, A., Fromm, J., Naresh, K.> ;Journal of Clinical Pathology. 2024 Feb 9
• Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Sustained, High Efficacy, and Safety With Long-Term Follow-Up.
  Carrie Ho, Ajay K Gopal, Brian G Till, Mazyar Shadman, Ryan C Lynch, Andrew J Cowan, Qian V Wu, Jenna Voutsinas, Heather A Rasmussen, Katherine Blue, Chaitra S Ujjani,...> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Feb 1
• A Review of the Flow Cytometric Findings in Classic Hodgkin Lymphoma, Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte-Rich Large B Cell Lymphoma.
  Feras Ally, David Gajzer, Jonathan R Fromm> ;Clinics in Laboratory Medicine. 2023 Sep 1
• 1 citations
  Flow Cytometry of CD5-Positive Hairy Cell Leukemia.
  Diana Cenariu, Ioana Rus, Jon Thor Bergthorsson, Ravnit Grewal, Mihai Cenariu, Victor Greiff, Adrian-Bogdan Tigu, Delia Dima, Cristina Selicean, Bobe Petrushev, Mihnea...> ;Molecular Diagnosis & Therapy. 2023 Sep 1
• MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte-predominant Hodgkin lymphoma.
  Alireza Torabi, Jonathan R Fromm, Naresh, K.> ;Ejhaem. 2023 May 1
• Skin Lesions as a Presenting Feature of Dimorphic T-Lymphoblastic Leukemia in an Adolescent Male.
  Stacy Chapman, Muhamad Almiski, Daniel Marko, Debora Sekiguchi, A J Dawson, Richard Keijzer, Jonathan Fromm, Sara J Israels> ;Journal of Pediatric Hematology/oncology. 2023 May 1
• 1 citations
  Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL.
  Solomon A Graf, Ryan C Lynch, Chaitra S Ujjani, Ted A Gooley, Heather Rasmussen, David G Coffey, Andrew J Cowan, Stephen D Smith, Mazyar Shadman, Edus H Warren, Edward...> ;Blood Advances. 2023 Mar 14
• 3 citations
  Peripheral lymphocytes and lactate dehydrogenase correlate with response and survival in head and neck cancers treated with immune checkpoint inhibitors.
  Cassie Pan, Qian Vicky Wu, Jenna Voutsinas, Jeffrey J Houlton, Brittany Barber, Zain H Rizvi, Emily Marchiano, Neal Futran, George E Laramore, Jay J Liao, Upendra Parv...> ;Cancer Medicine. 2023 Apr 1
• 5 citations
  Neutrophil to lymphocyte ratio and peripheral blood biomarkers correlate with survival outcomes but not response among head and neck and salivary cancer treated with p...
  Cassie Pan, Qian Vicky Wu, Jenna Voutsinas, Jeffrey J Houlton, Brittany Barber, Neal Futran, George E Laramore, Jay J Liao, Upendra Parvathaneni, Renato G Martins, Jon...> ;Head & Neck. 2023 Feb 1
• Predictors of risk of relapse in classic Hodgkin lymphoma.
  Jonathan R Fromm, Claire Tang, Naresh, K.> ;Journal of Clinical Pathology. 2023 Jun 1
• 6 citations
  "Blasts" in myeloid neoplasms - how do we define blasts and how do we incorporate them into diagnostic schema moving forward?
  Xueyan Chen, Jonathan R Fromm, Naresh, K.> ;Leukemia. 2022 Feb 1
• 3 citations
  A comparison and review of the flow cytometric findings in classic Hodgkin lymphoma, nodular lymphocyte predominant Hodgkin lymphoma, T cell/histiocyte rich large B ce...
  Daniel S Martig, Jonathan R Fromm> ;Cytometry. Part B, Clinical Cytometry. 2022 Jan 1
• 1 citations
  Clinicopathologic Findings in Patients With Initial Diagnosis of Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) in Colorectal Muc...
  Lorinda Soma, Stephen D. Smith, Prathima Reddy, Kerstin L. Edlefsen, David Wu, Sindhu Cherian, Xueyan Chen, Yi Zhou, Deepti M. Reddi, Jonathan R. Fromm> ;American Journal of Clinical Pathology. 2021 Aug 31
• 25 citations
  Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single cen...
  Ryan C. Lynch, Ryan D. Cassaday, Stephen D. Smith, Jonathan R. Fromm, Andrew J. Cowan, Edus H. Warren, Mazyar Shadman, Andrei R. Shustov, Brian G. Till, Chaitra S. Ujj...> ;The Lancet. Haematology. 2021 Aug 1
• 7 citations
  De Novo Identification and Visualization of Important Cell Populations for Classic Hodgkin Lymphoma Using Flow Cytometry and Machine Learning.
  Paul D. Simonson, Yue Wu, David Wu, Jonathan R. Fromm, Aaron Y. Lee> ;American Journal of Clinical Pathology. 2021 Nov 8
• 9 citations
  Evaluation of Preclinical Activity of Isatuximab in Patients with Acute Lymphoblastic Leukemia.
  Anlai Wang, Zhili Song, Gang Zheng, Céline Nicolazzi, Jonathan R. Fromm, Elvis Shehu, Srimathi Srinivasan, Xueyan Chen, Chen Zhu, Marielle F. Chiron Blondel, Francisco...> ;Molecular Cancer Therapeutics. 2021 Aug 10
• 2 citations
  Creating Virtual Hematoxylin and Eosin Images using Samples Imaged on a Commercial CODEX Platform.
  Paul D Simonson, Xiaobing Ren, Jonathan R Fromm> ;Journal of Pathology Informatics. 2021 Jan 1
• 15 citations
  Multicenter phase 2 study of daratumumab monotherapy in patients with previously treated Waldenström macroglobulinemia.
  Jorge J. Castillo, Edward N. Libby, Stephen M. Ansell, M. Lia Palomba, Kirsten Meid, Catherine A Flynn, Carly Leventoff, Christopher B. Hergott, Tomasz Sewastianik, El...> ;Blood Advances. 2020 Oct 27
• 17 citations
  Phase 2 study of pembrolizumab for measurable residual disease in adults with acute lymphoblastic leukemia.
  Ryan D. Cassaday, Kelsey-Leigh A. Garcia, Jonathan R. Fromm, Mary-Elizabeth M. Percival, Cameron J. Turtle, Paul Nghiem, Phillip A. Stevenson, Elihu H. Estey> ;Blood Advances. 2020 Jul 28
• 10 citations
  Flow cytometric features of incidental indolent T lymphoblastic proliferations.
  Jonathan R. Fromm, Kerstin L. Edlefsen, Sindhu Cherian, Brent L. Wood, Lori Soma, David Wu> ;Cytometry. Part B, Clinical Cytometry. 2020 May 1
• 101 citations
  A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer.
  Cristina P. Rodriguez, Qian Vicky Wu, Jenna M. Voutsinas, Jonathan R. Fromm, Xiuyun Jiang, Venu G. Pillarisetty, Sylvia Lee, Rafael Santana-Davila, Bernardo H. L. Goul...> ;Clinical Cancer Research. 2020 Feb 15
• 59 citations
  Pembrolizumab with R‐CHOP in previously untreated diffuse large B‐cell lymphoma: potential for biomarker driven therapy
  Stephen D. Smith, Brian G. Till, Mazyar Shadman, Ryan C. Lynch, Andrew J. Cowan, Qian Wu, Jenna M. Voutsinas, Heather Rasmussen, Katherine Blue, Chaitra S. Ujjani, And...> ;British Journal of Haematology. 2020 Feb 6
• 5 citations
  Impact of Double- or Triple-Hit Pathology on Rates and Durability of Radiation Therapy Response Among Patients With Relapsed or Refractory Large B-Cell Lymphoma.
  A. Kim, Philip A. Stevenson, Ryan D. Cassaday, Lori Soma, Jonathan R. Fromm, Ajay K. Gopal, Stephen D. Smith, Brian G. Till, Ryan C. Lynch, Chaitra S. Ujjani, Mazyar S...> ;Practical Radiation Oncology. 2020 Jan 1
• 3 citations
  Immunophenotypic Characterization and Purification of Neoplastic Cells from Lymph Nodes Involved by T‐Cell/Histiocyte‐rich Large B‐cell Lymphoma by Flow Cytometry and ...
  Emily Glynn, Jonathan R. Fromm> ;Cytometry. Part B, Clinical Cytometry. 2020 Jan 1
• Join now to see all

Journal Articles

• Mass Cytometry of Hodgkin Lymphoma Reveals a CD4+ Exhausted T-effector and T-regulatory Cell Rich Microenvironment  
  David Wu, Margaret A Shipp, Jonathan R Fromm, Philippe Armand, Scott J Rodig, Blood

Abstracts/Posters

• Comparative Genomic Analyses Defines Shared and Unique Features of cHL and PMBL and New Mechanisms of Sensitivity to PD-1 Blockade
  Jonathan R. Fromm, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Diffuse Large B-Cell Lymphoma Is Infiltrated with Functional CD8+ T-Cells Lacking the Hallmarks of Exhaustion
  Jonathan R. Fromm, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Pembrolizumab in Combination with Standard RCHOP Therapy for Previously Untreated Diffuse Large B-Cell Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Comprehensive Genomic Analysis of Flow-Sorted Hodgkin Reed Sternberg Cells Reveals Additional Genetic Bases of Immune Evasion 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018